MORF4L1 and metabolic dysfunction-associated steatohepatitis: Alternatively, the epigenetic remodeler MORF4-related gene on chromosome 15 (MRG15) could be targeted for the treatment of MASH due to LRH-1’s role in mediating rhythmic MRG15 recruitment to lipid synthesis genes48,49.